A longitudinal evaluation of clinical microbiology laboratory proficiency in a large-scale urban eqa program: insights into diagnostic accuracy and antimicrobial resistance surveillance (2022–2025)
Аннотация
External quality assessment (EQA) is an essential component of clinical microbiology, ensuring diagnostic reliability and underpinning antimicrobial resistance (AMR) surveillance. However, longitudinal data evaluating inter-tier laboratory performance and process stability in large urban healthcare networks remain limited. This study aimed to longitudinally evaluate the diagnostic proficiency of clinical microbiology laboratories in Ho Chi Minh City from 2022 to 2025, identifying pathogen-specific technical challenges and analyzing performance trajectories across different laboratory capacity tiers. A retrospective analysis was conducted using cumulative EQA data from 244 participating laboratories. Proficiency was evaluated across 3365 analytical challenges, encompassing Gram staining, bacterial identification (ID), quantitative urine culture, and antimicrobial susceptibility testing (AST). Laboratories were stratified into four structural capacity groups (A, B, C1, and C2). Performance trends and inter-tier disparities were evaluated using Cochran-Armitage trend tests, Pearson Chi-square analysis, and p-control charts. The regional laboratory network demonstrated high diagnostic proficiency, with a four-year pooled unacceptable rate of just 2.4%. A p-chart analysis confirmed that the system remained entirely within statistical control limits (UCL = 4.1%, LCL = 0.7%). Diagnostic errors were highly pathogen-specific, notably concentrated in fastidious or morphologically ambiguous organisms such as Listeria monocytogenes (26.3% Gram stain error in 2023) and Klebsiella pneumoniae (12.2% ID error in 2025). Conversely, flawless accuracy (0.0% error) was achieved in identifying critical multidrug-resistant organisms (MRSA, VRE, and ESBL-producers). Crucially, the proportion of all laboratories achieving perfect 100% target scores increased significantly over time ( p < 0.001). By the end of the study, the EQA program had effectively bridged initial capacity gaps, culminating in no significant statistical difference among tiers in achieving perfect diagnostic scores (Group A: 57.5% vs. Group C1 53.0%; p = 0.595). Sustained participation in the EQA program successfully drives continuous quality improvement and maintains robust systemic stability. The program exhibits a powerful equalizing effect, enabling resource-limited laboratories to bridge initial capacity gaps and attain diagnostic excellence comparable to centralized, high-capacity institutions.